Check out your Company Bowl for anonymous work chats.
Using š antibodies from a hyper-immune human donor, scientists have developed an antivenom for the world's deadliest snakes. āThe donor, for a period of nearly 18 years, had undertaken hundreds of bites and self-immunizations with escalating doses from 16 species of very lethal snakes that would normally a kill a horse,ā first author Dr Jacob Glanville explained. Read more and check out the study: https://www.linkedin.com/pulse/antivenom-neutralizes-neurotoxins-19-deadliest-snakes-elsevier-m2eve/?trackingId=m%2FvT85LVTGeSc2FJjMO5Ig%3D%3D
With Scopus AI, you can now take your research on the go! Scopus AIās latest updates offer an optimized mobile experience, enabling you to navigate the full depth of Scopus knowledge anytime, anywhere. Weāve also introduced new features to optimize your research workflow, including the ability to revisit and build upon previous queries, ask follow-up questions, and easily identify emerging research trends - all supported by curated and comprehensive Scopus data. Learn more on: http://spkl.io/6045fLvml
Elsevier has pushed roughly half a million ClinicalTrials.gov entries into Embase, its subscription biomedical database. The update lets R&D teams run a single search that pulls trial data from 200āplus countries and matches it with Embaseās peerāreviewed papers, ināpress manuscripts and conference abstracts. Elsevier notes that traditional approaches to synthesizing data from multiple sources is error prone and tedious. According to Mirit Eldor, Managing Director of Life Sciences at Elsevier, the move addresses a clear need. āResearchers are under increasing pressure to conduct comprehensive evidence searches with accuracy and efficiency, ensuring no critical information is overlooked,ā Eldor stated in the announcement. āThe incorporation of clinical trials data into Embase is the latest example of Elsevierās commitment to developing innovative solutions that enhance researchersā workflows.ā
This Nurses Week, we celebrate the incredible impact nurses have on transforming lives and shaping the future of healthcare. Your compassion, skill, and unwavering dedication make a difference every day. At Elsevier, we are proud to be your trusted partner on this journeyāfrom education to practiceāproviding the resources and tools you need to empower your growth and enhance your impact. Join us in honoring your contributions and explore Elsevierās nurse resource page for the latest insights and support as you continue to inspire meaningful change in every life you touch: http://spkl.io/6040f0ZZa
Have you ever felt ālostā in a movie? š§ In a recent study published in the Cell Press journal Neuron, researchers have mapped out what happens in our brains when weāre absorbed in a film. By using fMRI scans, a team at Massachusetts Institute of Technology was able to track 24 distinct brain networks that process different elements of movie scenesāfrom action and speech to social interactions and complex plot lines. The study found that our brain activity shifts based on the sceneās complexity. Straightforward scenes activate networks for language and object recognition, while more challenging scenes engage executive control networks responsible for problem-solving and comprehension. This innovative approach goes beyond traditional āresting stateā brain scans, showing us how our minds respond to dynamic stimuli in real-world conditions.
Saving lives through surgery is no longer exclusive to humans! The study published in Cell Press shows how Florida carpenter ants (Camponotus floridanus) treat their wounded nest-mates by cleaning or amputating infected limbs. Watch the ants in action.
How do you harness GenAIās transformative power for R&D while safeguarding scientific integrity? Experts share their insights and success stories. We all want to apply AI to improve patient outcomes. But how? āItās about passion,ā says Dr Ivan Krstic, Senior Director of Life Sciences at Elsevier, as moderator of the webinar Generative AI: Transforming Knowledge and Drug Design. āAnd I believe all of us here share this passion for harnessing computational advances to transform drug discovery and improve patient outcomes.ā Read more...
Director of Research Integrity & Publishing Ethics Sarah Jenkins leads the charge to protect research integrity. Fifteen years ago, when Sarah Jenkins was working as a Publisher and Publishing Director, managing allegations of ethical misconduct was a relatively straightforward part of the job. āCases were simpler in nature, relating mostly to authorial misconduct,ā she recalled. Today, the scenario is very different. āUnethical behavior can occur at many different stages within the research and editorial process,ā Sarah said. āAnd what weāre seeing is that it is increasingly intentionally hidden from us by the actors who are participating in that misconduct.ā Read more...
Prof Alexei Lapkin is transforming how scientists approach chemical synthesis. We spoke with him about his innovative technology and vision for a more sustainable chemical industry. Responses were edited for clarity and concision. In Elsevierās webinar AI in Action: Sustainability and Efficiency in Chemical Synthesis, Prof Alexei Lapkin and Dr Simon Wagschal of Lonza discuss the latest technological advancements in implementing sustainable and efficient practices in chemical synthesis planning. https://webinars.elsevier.com/elsevier/AI-in-Action-Sustainability-and-Efficiency-in-chemical-synthesis
In turbulent times such as now, universities have an even more critical role in helping to bridge ideological and political gaps ā and to ensure that the world remains connected, not only through economics and technology but through shared pursuit of knowledge and understanding. And building a better future for us all.
